Antisense K-ras RNA gene therapy
Latest Information Update: 23 Apr 2002
At a glance
- Originator Nonindustrial source
- Class Antineoplastics; Gene therapies
- Mechanism of Action KRAS protein modulators; Ras gene modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Colorectal cancer
Most Recent Events
- 28 Jul 2000 New profile
- 28 Jul 2000 Preclinical development for Colorectal cancer in Japan (Intratumoural)